163 related articles for article (PubMed ID: 33278331)
1. Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.
Woodley WD; Yue W; Morel DR; Lainesse A; Pettis RJ; Bolick NG
Clin Transl Sci; 2021 May; 14(3):859-869. PubMed ID: 33278331
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults.
Woodley WD; Morel DR; Sutter DE; Pettis RJ; Bolick NG
Clin Transl Sci; 2022 Jan; 15(1):92-104. PubMed ID: 34268888
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an investigational wearable injector in healthy human volunteers.
Torjman MC; Machnicki R; Lessin J; Loeum C; Steinberger D; Mycroft S; Joseph JI
Expert Opin Drug Deliv; 2017 Jan; 14(1):7-13. PubMed ID: 27809609
[TBL] [Abstract][Full Text] [Related]
4. A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers.
Portron A; Jordan P; Draper K; Muenzer C; Dickerson D; van Iersel T; Hofmann C
Clin Ther; 2020 Jan; 42(1):108-120.e1. PubMed ID: 31883703
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous administration of midazolam: a comparison of the Bioject jet injector with the conventional syringe and needle.
Bennett J; Nichols F; Rosenblum M; Condry J
J Oral Maxillofac Surg; 1998 Nov; 56(11):1249-54. PubMed ID: 9820211
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous Injection Site Pain of Formulation Matrices.
Shi GH; Pisupati K; Parker JG; Corvari VJ; Payne CD; Xu W; Collins DS; De Felippis MR
Pharm Res; 2021 May; 38(5):779-793. PubMed ID: 33942212
[TBL] [Abstract][Full Text] [Related]
7. Impact of Injection Speed, Volume, and Site on Pain Sensation.
Zijlstra E; Jahnke J; Fischer A; Kapitza C; Forst T
J Diabetes Sci Technol; 2018 Jan; 12(1):163-168. PubMed ID: 28990437
[TBL] [Abstract][Full Text] [Related]
8. Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.
Zijlstra E; Coester HV; Heise T; Plum-Mörschel L; Rasmussen O; Rikte T; Pedersen LK; Qvist M; Sparre T
Diabetes Obes Metab; 2018 May; 20(5):1140-1147. PubMed ID: 29369493
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.
Dias C; Abosaleem B; Crispino C; Gao B; Shaywitz A
AAPS PharmSciTech; 2015 Oct; 16(5):1101-7. PubMed ID: 25693652
[TBL] [Abstract][Full Text] [Related]
10. Clinical immunogenicity of measles, mumps and rubella vaccine delivered by the Injex jet injector: comparison with standard syringe injection.
Sarno MJ; Blase E; Galindo N; Ramirez R; Schirmer CL; Trujillo-Juarez DF
Pediatr Infect Dis J; 2000 Sep; 19(9):839-42. PubMed ID: 11001106
[TBL] [Abstract][Full Text] [Related]
11. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
[TBL] [Abstract][Full Text] [Related]
12. Performance of the pegfilgrastim on-body injector as studied with placebo buffer in healthy volunteers.
Joshi RS; Egbuna OI; Cairns AS; Friedman MJ; Abosaleem B; Reiner MT; Morrow PK
Curr Med Res Opin; 2017 Feb; 33(2):379-384. PubMed ID: 27819161
[TBL] [Abstract][Full Text] [Related]
13. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
[TBL] [Abstract][Full Text] [Related]
14. Clinical Investigation of Large Volume Subcutaneous Delivery up to 25 mL for Lean and Non-Lean Subjects.
Dang X; Shih H; Sharma R; Angwin-Kaerner DT; Lin K; Kapur S; Thyagarajapuram NR; Shi GH; Collins DS
Pharm Res; 2024 Apr; 41(4):751-763. PubMed ID: 38443633
[TBL] [Abstract][Full Text] [Related]
15. Advances in subcutaneous injections: PRECISE II: a study of safety and subject preference for an innovative needle-free injection system.
Kelley EL; Smith RH; Corcoran G; Nygren S; Jacoski MV; Fernandes A
Drug Deliv; 2021 Dec; 28(1):1915-1922. PubMed ID: 34541982
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site.
Usach I; Martinez R; Festini T; Peris JE
Adv Ther; 2019 Nov; 36(11):2986-2996. PubMed ID: 31587143
[TBL] [Abstract][Full Text] [Related]
17. Unintentional Epinephrine Auto-injector Injuries: A National Poison Center Observational Study.
Anshien M; Rose SR; Wills BK
Am J Ther; 2019; 26(1):e110-e114. PubMed ID: 27984266
[TBL] [Abstract][Full Text] [Related]
18. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
McKay M; Compion G; Lytzen L
Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
[TBL] [Abstract][Full Text] [Related]
19. Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates
.
Jain M; Doughty D; Clawson C; Li X; White N; Agoram B; van der Merwe R
Int J Clin Pharmacol Ther; 2017 Jul; 55(7):606-620. PubMed ID: 28590244
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers.
Berteau C; Schwarzenbach F; Donazzolo Y; Latreille M; Berube J; Abry H; Cotten J; Feger C; Laurent PE
Patient Prefer Adherence; 2010 Oct; 4():379-88. PubMed ID: 21049090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
